Authors:
Ripa, S
Zampaloni, C
Vitali, LA
Giovanetti, E
Montanari, MP
Prenna, M
Varaldo, PE
Citation: S. Ripa et al., SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes, MICROB DR R, 7(1), 2001, pp. 65-71
Authors:
Mannaerts, H
Li, Y
Kamp, O
Valocik, G
Hrudova, J
Ripa, S
Visser, C
Citation: H. Mannaerts et al., Quantitative assessment of mechanical prosthetic valve area by 3-dimensional transesophageal echocardiography, J AM S ECHO, 14(7), 2001, pp. 723-731
Authors:
Isaacsohn, J
Insull, W
Stein, E
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, CA
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
Citation: J. Isaacsohn et al., Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia, CLIN CARD, 24(9), 2001, pp. 1-9
Authors:
Insull, W
Isaacsohn, J
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, C
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
Citation: W. Insull et al., Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial, J INT MED R, 28(2), 2000, pp. 47-68
Citation: S. Bompadre et al., Quantification of trovafloxacin in serum by high-performance liquid chromatography with on-line solid-phase extraction, CHROMATOGR, 49(3-4), 1999, pp. 185-187
Authors:
Prenna, M
Montanari, MP
Mingoia, M
Biavasco, F
Ripa, S
Varaldo, PE
Citation: M. Prenna et al., Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin, EUR J CL M, 17(11), 1998, pp. 816-819